A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.
Conditions
Recurrent or Metastatic Nasopharyngeal Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Chongqing University Cancer Hospital, Chongqing, Chongqing Municipality, China
Fujian Cancer Hospital, Fuzhou, Fujian, China
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Zhangzhou Municiple Hospital of Fujian Province, Zhangzhou, Fujian, China
Dongguan People's Hospital, Dongguan, Guangdong, China
Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong, China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, China
Jiangmen Central Hospital, Jiangmen, Guangdong, China
Yuebei People's Hospital, Shaoguan, Guangdong, China
The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China
Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China
The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China
Hunan Cancer Hospital, Changsha, Hunan, China
Jiangxi Cancer Hospital, Nanchang, Jiangxi, China
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Sichuan Cancer Hospital, Chengdu, Sichuan, China
Yunnan Cancer Hospital, Kunming, Yunnan, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China